COLUMBUS, Ohio, July 23 (Nationwide Times) — For most people, the practical takeaway is simple: this study does not show that ordinary tomato juice is a proven anti-inflammation treatment. It does suggest that a specially made tomato-soy drink may change some inflammation markers in adults with obesity, but Ohio State researchers say the findings are early and need much larger studies.
What the study found
A study published in Molecular Nutrition & Food Research tested a tomato-soy beverage in 12 adults with obesity. After four weeks, the people who drank the special beverage had significant drops in three proteins linked to chronic inflammation: IL-5, IL-12p70 and GM-CSF, according to the study abstract indexed in PubMed.
The researchers also reported that TNF-alpha moved downward, but not enough to meet conventional statistical significance. In the same study, plasma lycopene rose 2.48-fold after the tomato-soy drink.
Why this is not the same as regular tomato juice
The beverage was not plain tomato juice. The study says it was made from tomatoes bred to contain high levels of lycopene and was fortified with soy isoflavones. Participants drank two 6-ounce servings a day.
That matters because the study compared the tomato-soy drink with a low-carotenoid tomato juice control. In other words, the result reflects a specially formulated product, not the kind of bottled juice most people buy at the store.
What the inflammation markers mean
The proteins measured in the study are part of the body’s immune signaling system. When they stay elevated for long periods, they can be associated with chronic inflammation, which has been linked to conditions such as heart disease and diabetes.
But the study did not test whether the drink prevented illness or improved long-term health. It only measured changes in biomarkers over a short period.
That is why the result is best read as a signal worth studying further, not as a reason to start treating tomato drinks like medicine.
How strong is the evidence?
Not very strong yet. The trial involved only 12 adults and lasted four weeks. The study used a crossover design with a washout period, but the sample was still very small.
Ohio State researchers and secondary coverage of the study both describe the finding as promising but preliminary. Larger studies would be needed before anyone could make broad dietary recommendations.
The study also found changes in the urine metabolome after both interventions, which the researchers said suggests some effects may come from tomato components beyond lycopene alone.
Has tomato juice been studied before?
Yes. A separate 2013 randomized study in overweight or obese female students at Tehran University of Medical Sciences found that tomato juice lowered some inflammatory markers compared with water. In that study, IL-8 and TNF-alpha fell in the intervention group, and IL-6 dropped in obese subjects.
That earlier work is not the same trial as the Ohio State study, but together they show that tomato-based drinks have been of interest to researchers studying inflammation.
Bottom line
The new study suggests a specially designed tomato-soy drink may lower a few inflammation-linked proteins in adults with obesity. It does not show that regular tomato juice has the same effect, and it does not prove a long-term health benefit.
For now, the most accurate reading is that the study adds early evidence to a larger question: whether certain tomato compounds can help influence inflammation in the body.
